← All Kura Oncology, INC filings

Kura Oncology, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
KURA
Kura Oncology, INC
DEF: Kura Oncology Sets June 4th Annual Meeting
Kura Oncology, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 4, 2026, to elect directors, ratify auditor appointments, and vote on equity plan amendments.
NASDAQ
KURA
Kura Oncology, INC
DEFA14A: Kura Oncology Sets Date for Annual Stockholders Meeting, Seeks Approval on Key Proposals
Kura Oncology will hold its annual stockholders meeting on June 5, 2025, seeking votes on director elections, auditor ratification, executive compensation, and an equity incentive plan amendment.
NASDAQ
KURA
Kura Oncology, INC
DEF: Kura Oncology Seeks Stockholder Approval for Director Elections, Auditor Ratification, Executive Pay, and Equity Incentive Plan Amendment
Kura Oncology is holding its 2025 Annual Meeting of Stockholders to elect directors, ratify the appointment of Ernst & Young LLP, approve executive compensation, and amend the 2014 Equity Incentive Plan.
NASDAQ
KURA
Kura Oncology, INC
DEFA14A: Kura Oncology Sets Date for Annual Stockholders Meeting, Outlines Key Proposals
Kura Oncology will hold its annual stockholders meeting on June 5, 2024, to vote on director elections, auditor ratification, executive compensation, and an equity incentive plan amendment.
NASDAQ
KURA
Kura Oncology, INC
DEF 14A: Kura Oncology Seeks Stockholder Approval for Director Elections, Auditor Ratification, Executive Pay, and Equity Incentive Plan Amendment
Kura Oncology is holding its 2024 Annual Meeting of Stockholders on June 5, 2024, to vote on key proposals including director elections, auditor ratification, executive compensation, and an amendment to the equity incentive plan.